KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLiabilities from Discontinued OperationsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TherapeuticsMD (TXMD) Prepaid Assets (2016 - 2025)

TherapeuticsMD (TXMD) has disclosed Prepaid Assets for 15 consecutive years, with $3.6 million as the latest value for Q4 2024.

  • For the quarter ending Q4 2024, Prepaid Assets rose 151.24% year-over-year to $3.6 million, compared with a TTM value of $3.6 million through Dec 2024, up 151.24%, and an annual FY2024 reading of $3.6 million, up 151.24% over the prior year.
  • Prepaid Assets was $3.6 million for Q4 2024 at TherapeuticsMD, down from $3.8 million in the prior quarter.
  • Across five years, Prepaid Assets topped out at $5.5 million in Q4 2021 and bottomed at $231000.0 in Q1 2024.
  • Average Prepaid Assets over 5 years is $3.2 million, with a median of $3.7 million recorded in 2024.
  • The sharpest move saw Prepaid Assets crashed 54.05% in 2022, then surged 151.24% in 2024.
  • Year by year, Prepaid Assets stood at $5.0 million in 2020, then increased by 10.81% to $5.5 million in 2021, then plummeted by 54.05% to $2.5 million in 2022, then plummeted by 42.83% to $1.4 million in 2023, then soared by 151.24% to $3.6 million in 2024.
  • Business Quant data shows Prepaid Assets for TXMD at $3.6 million in Q4 2024, $3.8 million in Q3 2024, and $3.7 million in Q2 2024.